Canagliflozin Alternatives in Maryland
Compare generic and therapeutic alternatives to Canagliflozin (canagliflozin) available at Maryland pharmacies. Save up to 48% on your prescription — no insurance required.
Top Alternatives in Maryland
Metformin
therapeutic
First-line T2D medication — dramatically cheaper
Avg cash price: $8/mo
Dapagliflozin (Farxiga)
therapeutic
Competing SGLT2 inhibitor with similar profile
Avg cash price: $530/mo
Empagliflozin (Jardiance)
therapeutic
SGLT2 inhibitor with strong cardiovascular outcomes data
Avg cash price: $560/mo
Maryland Prescription Assistance Programs
SPDAP (Senior Prescription Drug Assistance Program)
Subsidises Medicare Part D premiums and cost-sharing for eligible low-income Maryland seniors and adults with disabilities.
Eligibility: Maryland residents aged 65+ (or adults with disabilities) enrolled in Medicare Part D with income between 100-300% FPL. Contact the Maryland Department of Aging at 1-800-243-3425.
Maryland Medicaid Rx
Comprehensive prescription drug coverage through Maryland Medicaid (HealthChoice) managed care for eligible residents.
Eligibility: Low-income Maryland adults up to 138% FPL, children, pregnant women, and people with disabilities.
Frequently Asked Questions
Is there a generic for canagliflozin (Invokana)?
Not yet as of 2025. Canagliflozin is still under brand exclusivity as Invokana. All SGLT2 inhibitors remain brand-only at similar high prices.
How does canagliflozin compare to other SGLT2 inhibitors?
Canagliflozin, dapagliflozin, and empagliflozin have similar glucose-lowering effects. Differences emerge in cardiovascular and renal outcomes data — your cardiologist or endocrinologist guides the choice.
What is the main risk specific to canagliflozin?
Canagliflozin carries an FDA warning about increased risk of lower-limb amputations, particularly in patients with peripheral vascular disease. Discuss your individual risk with your doctor.
Can Script Unlock help with canagliflozin costs?
While there is no generic, Script Unlock pharmacies sometimes offer lower cash-pay brand pricing. It is worth posting your script to compare bids.
Is metformin a good alternative to canagliflozin for T2D?
Metformin is first-line T2D therapy at under $10/month. SGLT2 inhibitors like canagliflozin are added for patients who need additional cardiovascular or renal benefits beyond glucose lowering.